Hyloris Pharmaceuticals SA
LSE:0AB6
Hyloris Pharmaceuticals SA
LSE:0AB6
Price:
4.7
EUR
-16.07%
Market Cap:
€1.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Hyloris Pharmaceuticals SA
LSE:0AB6
|
BE |
|
GCL New Energy Holdings Ltd
HKEX:451
|
HK |
|
Frasers Centrepoint Trust
OTC:FRZCF
|
SG |
|
A
|
American West Metals Ltd
ASX:AW1
|
AU |
Cash Flow Statement
Cash Flow Statement
Hyloris Pharmaceuticals SA
Hyloris Pharmaceuticals SA
Currency: EUR
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net Income |
(12)
|
(12)
|
(8)
|
(11)
|
(12)
|
(16)
|
(13)
|
(6)
|
(6)
|
|
| Depreciation & Amortization |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Non-Cash Items |
1
|
1
|
1
|
1
|
0
|
0
|
(1)
|
0
|
2
|
|
| Cash Taxes Paid |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
(0)
|
0
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(4)
|
(1)
|
(1)
|
(2)
|
1
|
2
|
2
|
(1)
|
(3)
|
|
| Cash from Operating Activities |
(14)
N/A
|
(11)
+19%
|
(8)
+26%
|
(13)
-56%
|
(11)
+17%
|
(13)
-19%
|
(12)
+5%
|
(7)
+43%
|
(7)
+0%
|
|
| Investing Cash Flow | ||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Items |
(1)
|
(2)
|
(1)
|
(11)
|
(5)
|
11
|
6
|
1
|
(1)
|
|
| Cash from Investing Activities |
(1)
N/A
|
(3)
-125%
|
(3)
+16%
|
(11)
-339%
|
(6)
+50%
|
10
N/A
|
5
-46%
|
0
-95%
|
(1)
N/A
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(15)
|
(0)
|
(1)
|
(7)
|
(6)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
17
|
0
|
13
|
12
|
(1)
|
(0)
|
(0)
|
0
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
(0)
N/A
|
15
N/A
|
8
-48%
|
(7)
N/A
|
(0)
+98%
|
(0)
+40%
|
(0)
-113%
|
(0)
-93%
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
| Net Change in Cash |
(13)
N/A
|
(14)
-8%
|
4
N/A
|
(17)
N/A
|
(24)
-42%
|
(3)
+87%
|
(7)
-127%
|
(7)
+2%
|
(9)
-29%
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(14)
N/A
|
(12)
+14%
|
(9)
+23%
|
(14)
-45%
|
(12)
+16%
|
(14)
-18%
|
(13)
+6%
|
(7)
+44%
|
(7)
-2%
|
|
Switch to:
Switch to:
See Also
Discover More
